Choose your font:
 Mukta Malar
 Open Sans Condensed
 Source Sans Pro


[Valid RSS] RSS

Database - Alliance francophone pour l'accouchement respecté (AFAR)

Description of this bibliographical database (AFAR website)
Currently 3032 records
YouTube channel (tutorial)

Created on : 24 May 2005
Modified on : 02 Dec 2007

 Modify this record
Do not follow this link unless you know an editor’s password!

Share: Facebook logo   Tweeter logo   Easy

Bibliographical entry (without author) :

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? Commentary. Canadian Medical Association Journal 2005;172(11):1457-1459.

Author(s) :

Koren G, Matsui D, Einarson A, Knoppert D, Steiner M.

Year of publication :


URL(s) :…

Résumé (français)  :

Abstract (English)  :

Last summer, the US Food and Drug Administration instructed manufacturers of antidepressants to issue warnings about perinatal complications associated with their products.1 Physicians were advised to taper the dosage of antidepressants in pregnant women during the last trimester so that the fetus receives no drug for at least 7–10 days before delivery. A month later, Health Canada followed suit; the Canadian advisory2 similarly suggested that "Physicians may consider slowly decreasing the dose of these medications in the third trimester." These advisories were based on "reports reveal[ing] that some newborns whose mothers took these medications during pregnancy have developed complications at birth."2 These complications were seen as consistent with withdrawal symptoms or a direct adverse effect by the antidepressant on the baby.

We believe those recommendations are only partially evidence-based and may put the depressed mother-to-be and her baby at an unreasonable health risk. This paper presents a brief discussion of the pattern of neonatal symptoms observed after maternal use of selective serotonin or serotonin– norepinephrine reuptake inhibitors (SSRIs or SNRIs, respectively).

Sumário (português)  :

Full text (private) :

 ➡ Access requires authorization

Comments :

Texte en accès libre.

Argument (français) :

Femmes en dépression grave pendant la grossesse: il n’est pas certain que supprimer ou diminuer les
antidépresseurs pendant le 3e trimestre soit moins nocif pour le bébé que de les continuer.

Argument (English):

Argumento (português):

Keywords :

➡ depression, anxiety ; pathologies of newborn ; psychology

Author of this record :

Cécile Loup — 24 May 2005

Discussion (display only in English)
➡ Only identified users

 I have read the guidelines of discussions and I accept all terms (read guidelines)


New expert query --- New simple query

Creating new record --- Importing records

User management --- Dump database --- Contact


This database is managed by Alliance francophone pour l'accouchement respecté (AFAR,
affiliated with Collectif interassociatif autour de la naissance (CIANE,
It is fed by the voluntary contributions of persons interested in the sharing of scientific data.
If you agree with this project, you can support us in several ways:
(1) contributing to this database if you have a minimum training in documentation
(2) or financially supporting AFAR (see below)
(3) or joining the AFAR (or another society affiliated with CIANE).
Sign in or create an account to follow changes or become an editor.
Contact afar.association(arobase) for more information.

Valid CSS! Valid HTML!
Donating to AFAR (click “Faire un don”) will help us to maintain and develop sites and public
databases towards the support of parents and caregivers’ informed decisions with respect to childbirth